Inclusion Criteria:  The subject has signed an Institutional Review Board (IRB)-approved, study specific Informed Consent Form (ICF). The subject is skeletally mature The subject has a diagnosis as listed in the instructions for use (IFU), which include non inflammatory degenerative joint disease (including osteoarthritis or avascular necrosis), rheumatoid arthritis or post-traumatic arthritis, correction of functional deformity, treatment of nonunion, femoral neck and trochanteric fractures. The subject is a candidate for a primary or revision cementless THA. The subject is willing and able to comply with postoperative scheduled clinical evaluations.  Exclusion Criteria:  The subject is pregnant or breastfeeding The subject has an active or suspected latent infection in or about the affected hip joint at the time of study device implantation. The subject has any mental or neuromuscular disorder which would create an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complications in postoperative care. The subject has bone stock compromised by disease, infection or prior implantation which cannot provide adequate support and/or fixation to the prosthesis. The subject is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. > 30 days). The subject has a known sensitivity to device materials. The subject is involved in any ongoing legal matter, investigation, or dispute pertaining to the operative site. The subject is a prisoner.